Sun Pharmaceutical Industries Limited has informed the Exchange about Link of Recording

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.4%1-day move

₹1731.00

prior close

₹1724.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.2+0.5+0.4+1.0+2.4+4.6+5.3+5.0+6.9+6.6+8.6+4.2+8.2—

Up moveDown movePending

AI summary

Sun Pharmaceutical Industries Limited has disclosed an investor call held on 27 April 2026 regarding the acquisition of Organon & Co. The company has made the audio recording of this call available on its website under Regulation 30 of SEBI LODR Regulations, 2015. This disclosure comes from the company's corporate headquarters in Mumbai. The filing does not provide details about the terms, timeline, or strategic rationale of the proposed acquisition.

Likely market impact

The disclosure indicates Sun Pharma is actively communicating with investors about the Organon acquisition, but without deal terms or financial details, the impact on the stock remains neutral until more specifics emerge.